pharmacie et médicaments – Réduction plafond des remises commerciales sur les médicaments génériques

This written question asks about proposed changes to the maximum allowable commercial rebates for generic medicines in France. It seeks clarification on the potential impact of these changes on the pharmaceutical market and drug pricing. The question concerns pharmaceutical companies, generic drug manufacturers, and potentially patients, as it could affect the cost and availability of generic medications.